Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000256169 | SCV000321570 | pathogenic | not provided | 2020-06-09 | criteria provided, single submitter | clinical testing | Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 18821982) |
Labcorp Genetics |
RCV000525670 | SCV000630035 | pathogenic | Hypohidrotic X-linked ectodermal dysplasia | 2024-03-05 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 4 of the EDA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in EDA are known to be pathogenic (PMID: 9683615). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with ectodermal dysplasia (PMID: 18821982; Invitae). ClinVar contains an entry for this variant (Variation ID: 265107). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000525670 | SCV004099170 | likely pathogenic | Hypohidrotic X-linked ectodermal dysplasia | 2023-09-25 | criteria provided, single submitter | clinical testing | PP3_Strong, PS4_Supporting, PM2 |